Biomarkers and molecular epidemiology-present state and future trends: Concluding remarks

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 600, Issue 1-2, 2006, Pages 77-78

  Kyrtopoulos, Soterios A ^a   Sarrif, Awni ^b   Elliott, Barry M ^c   Schoket, Bernadette ^d   Demopoulos, Nikos A ^e  

^a INSTITUTE OF BIOLOGY   (Greece)

^b European Centre for Ecotoxicology and Toxicology of Chemicals   (Belgium)

^c JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^d Jozsef Fodor National Center for Public Health   (Hungary)

^e UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER RISK; DNA REPAIR; EDITORIAL; ENVIRONMENTAL EXPOSURE; GENETIC DAMAGE; GENETIC POLYMORPHISM; GENOMICS; LIFESTYLE; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EPIDEMIOLOGY, MOLECULAR; FORECASTING; HUMANS; NEOPLASMS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 33747607035     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.05.035     Document Type: Editorial

References (11)

1. Merlo D.F., Sormani M.P., and Bruzzi P. Molecular epidemiology: new rules for new tools?. Mutat Res. 600 (2006) 3-11
2. Hagmar L., Stromberg U., Bonassi S., Hansteen I.L., Knudsen L.E., Lindholm C., and Norppa H. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res. 64 (2004) 2258-2263
3. Rössner P., Boffetta P., Ceppi M., Bonassi S., Smerhovsky Z., Landa K., Juzova D., and Šrám R.J. Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ. Health Perspect. 113 (2005) 517-520
4. Norppa H., Bonassi S., Hansteen I.-L., Hagmar L., Strömberg U., Rössner P., Boffetta P., Lindholm C., Gundy S., Lazutka J., Cebulska-Wasilewska A., Fabiánová E., Šrám R.J., Knudsen L.E., Barale R., and Fucic A. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat. Res. 600 (2006) 37-45
5. Szukała K., Sowińska A., Wierzbicka M., Biczysko W., Szyfter W., and Szyfter K. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?. Mutat Res. 600 (2006) 67-76
6. Rundle A. Carcinogen-DNA adducts as a biomarker for cancer risk. Mutat. Res. 600 (2006) 23-36
7. Fenech M. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat. Res. 600 (2006) 58-66
8. Van Leeuwen D.M., van Herwijnen M.H.M., Pedersen M., Knudsen L., Kirsch-Volders M., Šrám R.J., Staal Y.C.M., Bajak E., van Delft J.H.M., and Kleinjans J.C.S. Genome-wide differential gene expression in children exposed to air pollution in the Czech Republic. Mutat. Res. 600 (2006) 12-22
9. Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat. Res. 600 (2006) 46-57
10. Holliday R. Endogenous DNA methylation and epimutagenesis. Mutat Res. 422 (1998) 97-100
11. Esteller M. Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv. Exp. Med. Biol. 532 (2003) 39-49